Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis

BACKGROUND: Topotecan is one of the most active chemotherapeutic drugs for small cell lung cancer (SCLC). However, its efficacy in elderly patients with SCLC has not been validated. This study evaluated the feasibility and efficacy of topotecan monotherapy in elderly patients with relapsed SCLC. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hisao, Yamada, Yutaka, Minemura, Hiroyuki, Sugiyama, Tomohide, Kotake, Mie, Kaira, Kyoichi, Kanazawa, Kenya, Nakamura, Yoichi, Kasai, Takashi, Shibata, Yoko, Kaburagi, Takayuki, Minato, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275829/
https://www.ncbi.nlm.nih.gov/pubmed/30281216
http://dx.doi.org/10.1111/1759-7714.12884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275829/
https://www.ncbi.nlm.nih.gov/pubmed/30281216
http://dx.doi.org/10.1111/1759-7714.12884

Ejemplares similares